Target intelligence / Profile preview

Kidney Excretion

Molecular classification
Other (physiological process), Involves multiple classes: Transporter (e.g., SGLT2, NHE3), Enzyme (e.g., Na+/K+ ATPase), Ion channel (e.g., potassium channels)
01

Overview

Kidney excretion refers broadly to the physiological processes by which the kidneys remove metabolic waste products and excess substances from circulation through urine formation. This involves glomerular filtration followed by selective tubular reabsorption and secretion mediated by various specialized proteins such as ion channels, active transporters for organic cations/anions/glucose/peptides, and water channels. Many drug classes act on these underlying molecular targets—such as SGLT2 inhibitors for diabetes or diuretics for hypertension—but there is no single molecule or receptor named "kidney excretion." The term encompasses complex interactions among numerous proteins within different nephron segments that collectively maintain fluid/electrolyte balance and eliminate toxins from the body. Modulation of these processes can have therapeutic benefits in diseases like chronic kidney disease or heart failure but also carries risks related to electrolyte disturbances and volume status alterations. In summary: “Kidney Excretion” should not be treated as an individual druggable target; it describes an essential multi-component biological function performed by many distinct molecules within renal physiology.

Other names
Renal excretionrenal eliminationurinary excretion
02

Mechanism of action

Mechanisms depend on the transporter/channel targeted; for example: Inhibition of glucose reabsorption by blocking SGLT2; Inhibition of sodium/proton exchange by blocking NHE3. No mechanism acts on "kidney excretion" generically.

03

Biological functions

Waste removalElectrolyte balanceAcid-base homeostasisWater reabsorption
04

Disease associations

Chronic kidney diseaseHeart failureHypertension
05

Safety considerations

Electrolyte imbalances (hyponatremia/hyperkalemia)Volume depletion/dehydration
06

Interacting drugs

SGLT2 inhibitors (e.g., dapagliflozin)

2 more in the full profile.

07

Biomarkers

Creatinine clearanceEstimated glomerular filtration rate (eGFR)

Beyond the preview

Go deeper on Kidney Excretion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kidney Excretion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call